Materias dentro de su búsqueda.
Mostrando 1,021 - 1,040 Resultados de 1,135 Para Buscar 'Ashenden: OR the British Agent*', tiempo de consulta: 0.26s Limitar resultados
  1. 1021
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma
  2. 1022
    “…BACKGROUNDS: N-acetylcysteine (NAC) has broadly been used as an anti-oxidant agent in various types of diseases. This study aimed to assess the effect of NAC on the systemic lupus erythematosus (SLE) disease activity and outcome. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study
  3. 1023
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clavibacter nebraskensis causing Goss's wilt of maize: Five decades of detaining the enemy in the New World
  4. 1024
    “…In the meantime, given all of the randomised evidence on the efficacy and toxicity associated with the regimens used in these trials, we conclude that single agent carboplatin is a safe and effective first-line treatment for women with advanced ovarian cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
  5. 1025
    “…PARTICIPANTS: The participating pharmacy staff screened consecutive patients, or agents of patients, who were dropping or picking up prescription medications. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality
  6. 1026
    por Ward, Christopher, Lee, Vincent
    Publicado 2014
    “…Of the 58 who didn't clear HCV, 12 (20.7%) were lost to follow up/transferred care, 4 (6.9%) declined treatment awaiting newer agents, and 10 (17.2%) are waiting to start. A total of 32 patients started treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Experience of acute hepatitis C and HIV co-infection in an inner city clinic in the UK
  7. 1027
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Validation of the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) chronic kidney disease risk score in HIV‐infected patients in the USA
  8. 1028
    por Arun, Tarunya
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    O08 Neurosarcoidosis mimicking CNS lymphoma
  9. 1029
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    High Plains wheat mosaic virus: An enigmatic disease of wheat and corn causing the High Plains disease
  10. 1030
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Xanthomonas arboricola pv. juglandis and pv. corylina: Brothers or distant relatives? Genetic clues, epidemiology, and insights for disease management
  11. 1031
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Common bacterial blight of bean: a model of seed transmission and pathological convergence
  12. 1032
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P46 Antibiotic susceptibility response of adeABC in the presence of a G-quadruplex DNA molecule
  13. 1033
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes
  14. 1034
    “…None of the studies considered the role of the podiatrist as a person-centred care agent. The data on interventions generated the following themes ‘service facilitated person-centred care’ where a change has been made to service delivery, ‘direct clinician delivery’ where the intervention is delivered by the clinician with the patient present and ‘patient instigated participation’ where patient motivation is required to engage with an activity beyond the consultation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The application, character, and effectiveness of person-centred care with service-users, and the community within the discipline of podiatry: a scoping review
  15. 1035
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    27 Single center inception cohort of enthesitis-related arthritis: spectrum of characteristics, course and treatment approaches
  16. 1036
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    07 Predictor factors of hip involvement in juvenile idiopathic arthritis
  17. 1037
    “…Humira(TM) is an anti-TNFa agent that was approved by Health Canada for the treatment of IBD. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A175 REAL-WORLD EXPERIENCE ON SWITCHING FROM ADALIMUMAB TO BIOSIMILARS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – AN OBSERVATIONAL STUDY FROM THREE TERTIARY CARE CENTRES
  18. 1038
    “…We have performed a phase II study examining the single agent activity of irinotecan in patients with metastatic relapsed or cisplatin-refractory germ cell cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
  19. 1039
    “…Taxanes have demonstrated immunostimulatory effects against neoplasms, supporting the idea that these agents suppress cancer through several mechanisms and not solely through inhibiting cell division. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
  20. 1040
    Publicado 2012
    “…Genetic studies in populations could be used more widely to help to validate and prioritise novel drug targets or to repurpose existing agents and targets for new therapeutic uses. FUNDING: UK Medical Research Council; British Heart Foundation; Rosetrees Trust; US National Heart, Lung, and Blood Institute; Du Pont Pharma; Chest, Heart and Stroke Scotland; Wellcome Trust; Coronary Thrombosis Trust; Northwick Park Institute for Medical Research; UCLH/UCL Comprehensive Medical Research Centre; US National Institute on Aging; Academy of Finland; Netherlands Organisation for Health Research and Development; SANCO; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Agentschap NL; European Commission; Swedish Heart-Lung Foundation; Swedish Research Council; Strategic Cardiovascular Programme of the Karolinska Institutet; Stockholm County Council; US National Institute of Neurological Disorders and Stroke; MedStar Health Research Institute; GlaxoSmithKline; Dutch Kidney Foundation; US National Institutes of Health; Netherlands Interuniversity Cardiology Institute of the Netherlands; Diabetes UK; European Union Seventh Framework Programme; National Institute for Healthy Ageing; Cancer Research UK; MacArthur Foundation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Herramientas de búsqueda: RSS